Kirk Wheeler Michel - 05 Jan 2024 Form 4 Insider Report for Pharma-Bio Serv, Inc. (PBSV)

Role
Chairman, Director
Signature
/s/ Kirk Michel
Issuer symbol
PBSV
Transactions as of
05 Jan 2024
Net transactions value
-$0.4
Form type
4
Filing time
09 Jan 2024, 20:34:22 UTC
Previous filing
28 Mar 2023
Next filing
12 Jan 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PBSV Common Stock Options Exercise $15,200 +20,000 +53% $0.7600 57,942 05 Jan 2024 Direct
transaction PBSV Common Stock Tax liability $15,200 -14,340 -25% $1.06 43,602 05 Jan 2024 Direct F1
holding PBSV Common Stock 340,706 05 Jan 2024 By Kema Advisors, Inc. F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PBSV Stock Option Options Exercise $0 -20,000 -100% $0.000000* 0 05 Jan 2024 Common Stock 20,000 $0.7600 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the aggregate amount of shares of Common Stock withheld for a cashless exercise.
F2 The reporting person is the sole shareholder of this entity.
F3 The option vested in two equal installments on July 10, 2020 and July 10, 2021.